BI signs schizophrenia app deal with Click TherapeuticsBoehringer Ingelheim has signed a $500 million contract with Click Therapeutics to co-develop and market a digital treatment Share XBI signs schizophrenia app deal with Click Therapeuticshttps://pharmaphorum.com/news/bi-signs-schizophrenia-app-deal-with-click-therapeutics/
